[ad_1]
New Delhi, Jul 3 (PTI) An international team of scientists is studying the causes of life-threatening sepsis and drug-resistant infections in babies in many countries, including India, in an effort to combat the infant mortality. 19659002] More than 80 researchers from 11 countries gathered in New Delhi to launch a study under the Expanded Global Antibiotic Research and Development Partnership (GARDP) program to develop new and improved antibiotic treatments for newborns. born. Since 1990, the number of preventable deaths among newborns remains unacceptable.
Neonatal deaths now account for 44% of all child deaths.
The estimated number of deaths among newborns attributable to drug-resistant infections is estimated at 214,000.
"Antibacterial resistance is one of Manica Balasegaram, director of GARDP, said:" This The study is conducted in hospitals and neonatal units in many countries, including India, Bangladesh, Brazil, China and the South.The study, funded by the Bill & Melinda Gates Foundation, will generate a strong foundation of evidence on how neonatal sepsis is managed and which can be used as a basis for badessing future infections.
Mortality, antibiotic use and duration of antimicrobial therapy count among the results of interest – there is currently little data on these parameters
Septicemia, the body's response to infection, can be life-threatening and a particular threat tonewborns because their immune system is not fully developed.
Increasing rates of resistant bacteria to existing treatments are reported in hospitalized infants and infants at high risk of developing drug-resistant nosocomial infections.
The vulnerability of newborns to sepsis is compounded by the difficulty of diagnosing serious bacterial infections since the symptoms and signs may be nonspecific and difficult to detect.
The data generated by the study will inform the GARPD's ambition to develop and provide new antibiotic treatments to newborns with drug-resistant bacterial infections.
Limited research on neonates has resulted in a lack of evidence of resistant infections in this vulnerable population. PTI MHN SAR MHN
MHN
This is an unedited, unformatted feed from the Press Trust of India feed.
[ad_2]Source link
